CRVS - CIK 0001626971
As of 2026-06-10, Corvus Pharmaceuticals, Inc. (CRVS) has a market capitalization of $945.18 M, making it the #2651 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-10 | $945.18 M |
| 2026-05-29 | $1.03 B |
| 2026-05-28 | $1.09 B |
| 2026-05-26 | $1.10 B |
| 2026-05-25 | $1.06 B |
| 2026-05-24 | $1.06 B |
| 2026-05-22 | $1.06 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-10, Corvus Pharmaceuticals, Inc. (CRVS) has a market capitalization of $945.18 M, making it the #2651 most valuable US-listed company.
Corvus Pharmaceuticals, Inc. is the #2651 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.